Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Non-inferiority (Phase 2), Comparing Dapaconazole (BL123 - Biolab Sanus Farmacêutica Ltda.) Versus Miconazole Nitrate (União Química) in Patients With a Single Lesion of Tinea Cruris.

NCT03359070 is registered in ClinicalTrials.gov with Galeno Desenvolvimento de Pesquisas Clínicas as lead sponsor.

NCT NCT03359070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03359070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Non-inferiority (Phase 2), Comparing Dapaconazole (BL123 - Biolab Sanus Farmacêutica Ltda.) Versus Miconazole Nitrate (União Química) in Patients With a Single Lesion of Tinea Cruris.
Lead sponsor
Galeno Desenvolvimento de Pesquisas Clínicas
Phase
Phase 2
Overall status
Completed
Start date
January 29, 2014
Completion date
May 6, 2015
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinea cruris